drugset / Trial / NCT01419353

Programming by Estrogen Treatment in Gonadotropin Releasing Hormone Antagonist Protocol

NCT01419353

Phase 4 Completed 63 enrolled Meir Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if pretreatment with Estrogen can assist in the planning and programming of In Vitro Fertilization treatments.

Timeline

Start
2011-08
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject estradiol valerate Unknown 2 mg Oral

Indications